Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Fennec Pharmaceuticals (RV41.F) Q2 2025 Earnings
RV41.F
13
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.14
-0.08
-0.02
Details
Expected EPS
-0.0788040724897796
Actual EPS
-0.034721156425925596
Surprise EPS
0.04
Surprise Percent
+55.94%
Description
Fennec Pharmaceuticals (RV41.F) has reported earnings of -0.034721156425925596 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login